Skip to main content
Brain-stem lesions, including those in the midbrain, are known to cause hallucinatory delusions (13). However, to our knowledge, there have been no reports of such cases occurring with symptoms limited to delusions without hallucinations. Here, we report a case of a minor midbrain lesion in a patient who presented with delusions without hallucinations.
The study was approved by the ethics committee of Shinoda General Hospital. Written informed consent was obtained from the patient and the patient’s family in accordance with the Declaration of Helsinki guidelines.

Case Report

A 77-year-old, right-handed man who complained of problems with articulation, walking, and diplopia was admitted to the hospital. The patient had 12 years of education and no past history of mental or neurological disorders. Three weeks after admission, he requested rehabilitation and was transferred to our facility. Neurologically, he presented with right-medial longitudinal fasciculus syndrome, bilateral cerebellar ataxia in both arms and legs (more notable on the left side), cerebellar dysarthria, rapid speech, and micrographia. No other neurological abnormalities were found. Head diffusion MRI revealed an infarct in the lower part of the midbrain (Figure 1).
FIGURE 1. Head diffusion-weighted MRI of a patient with a minor midbrain lesion presenting with delusions without hallucinationsa
a The images show an infarct in the midbrain below the red nucleus. The lesion was detected in the right cerebral peduncle and spanned from the anterior to posterior edges. No other lesions were present. L=left, R=right.
At each therapy session, the patient expressed the following complaints to the therapist: “Someone deleted the address book in my Smartphone”; “Someone will steal my money and kill me, so I must die”; and “My wife is having an affair.” None of these claims were true, and the therapist pointed out their irrational nature, but the patient refused to agree. He also made comments suggestive of a depersonalized state, such as, “I feel like I am in space—this is not reality”; and “It feels like this is not my world.” No visual, auditory, or tactile hallucinations were observed, nor were depressive or sleep-wake disorders.
Several neuropsychological tests were applied in order to assess the patient’s general cognition, general attention, hemispatial neglect, and frontal-executive function. General cognition was evaluated with the Mini-Mental State Examination (MMSE) (4), while general attention was tested with the digit and spatial span tasks of the Wechsler Memory Scale–Revised (5). Hemispatial neglect was examined with the Catherine Bergego Scale (6) and the Behavioral Inattention Test (7). Frontal-executive function was assessed with the Frontal Assessment Battery (FAB) (8), the Trail-Making Test, Part A (TMT-A) and Part B (TMT-B) (9), and the Behavioral Assessment of the Dysexecutive Syndrome (BADS) (10). The results of the digit span and spatial span tasks, as well as those of the TMT-A, TMT-B, and FAB, were expressed as z scores adjusted for age, in accordance with a previously described method (11). These results are summarized in Table 1. The patient’s general cognition and attention were normal, and he showed no hemispatial neglect. However, his z scores on the FAB, TMT-A, and TMT-B were −4.1, 5.6, and 13.0 respectively, and he had a score of 69/129 on the BADS (scores of 19–69 indicate impairment). These scores were indicative of abnormalities in frontal-executive function. His episodic memory did not appear to be impaired, because he was able to recall three items from the MMSE. In addition, he could remember the faces, names, and hometowns of all of the therapists with whom he had worked. Finally, he was able to give accurate oral descriptions of the contents of his previous day’s training.
TABLE 1. Results of the patient’s neuropsychological examinations
 Initial scorea4-Month follow-up scorea
TestRawzRawz
General cognition    
 Mini-Mental State Examinationb30NA30NA
General attention    
 Digit spanc130.316–0.8
 Spatial spand131.1170.7
Hemispatial neglect    
 Catherine Bergego Scalee0NA0NA
 Behavioral Inattention Test, conventional subtestsf142NANANA
Frontal-executive function    
 Frontal Assessment Batteryg6–4.1181.1
 Trail-Making Test, Part A (seconds)1055.6510.4
 Trail-Making Test, Part B (seconds)41013.01904.1
 Behavioral Assessment of the Dysexecutive Syndromeh69NA114NA
a
NA=not applicable.
b
Score range, 0–30 (cut-off score 23/24).
c
Score range, 0–24.
d
Score range, 0–26.
e
Score range, 0–30 (higher scores indicate severe neglect).
f
Score range, 0–146 (cut-off score, 131/132).
g
Score range, 0–18.
h
The data represent a standardized score with a mean of 100 and standard deviation of 15.
The patient’s persecutory delusions, delusional jealousy, and depersonalized comments continued daily for more than 1 month but gradually decreased. After 4 months, his complaints of delusions and depersonalizations ceased. He showed great improvement in frontal-executive function, as indicated by the results of neuropsychological tests (z scores on the FAB, TMT-A, and TMT-B: z=1.1, z=0.4, z=4.1, respectively; BADS score, 114/129).

Discussion

Our patient experienced delusions without hallucinations resulting from a midbrain infarction. Peduncular hallucinosis is a mental symptom that is known to occur after damage to the midbrain or pons (12). However, instead of delusions, complex visual or tactile hallucinations occur. Generally, the patient is aware of the hallucinations and often has a sleep-wake rhythm disorder. In contrast with peduncular hallucinosis, our patient did not present with hallucinations. Other reports have described cases in which a lesion in the midbrain or pons led to hallucinations and delusions without awareness (13). However, there are no reports, to our knowledge, of a patient presenting only with delusions in the absence of hallucinations following damage to these sites, thus making the patient in the above case unique. In reports of localized damage, noradrenergic neuron abnormalities were hypothesized to have caused psychosis in a patient who had surgery on the mesencephalic tegmentum (1), whereas dopaminergic neuron abnormalities were assumed to be the cause of a case of psychosis following substantia nigra infarction (2). Nishio et al. (2) reported a case in which various frontal lobe symptoms, hallucinations, and delusions developed after infarction of the substantia nigra, and single-photon emission computerized tomography revealed decreased circulation in the frontal lobe. The authors assumed that disruption of ascending dopaminergic projections to the frontal-subcortical circuits was the cause of the altered mental symptoms.
Right-hemisphere brain damage is commonly reported in cases of delusions after stroke (13). In a systematic review of poststroke psychosis, lesions typically occurred in the right hemisphere, and the most common psychosis was delusional disorder (14). These findings suggest that right-hemisphere lesions, or networks with key nodes in the right hemisphere, may play a role in the development of delusions. Devinsky (15) suggested that delusions arise when the unchecked left hemisphere unleashes a “creative narrator” from the monitoring of self, memory, and reality—functions typically performed by the frontal- and right-hemisphere areas. Coltheart (16) similarly proposed that one of the factors in the development of delusions is a defective “belief evaluation system,” localized in the right frontal cortex. In our patient, MRI revealed lesions that involved the right substantia nigra. Notably, the substantia nigra is directly connected with the frontal cortex (17) and has dopaminergic projections to frontal-subcortical circuits that modulate frontal lobe functions. Disturbances of these direct or indirect pathways to the right frontal lobe may be essential in the development of a patient’s delusions. This hypothesis is supported by our observation of abnormalities revealed by frontal executive function tests when our patient exhibited delusional beliefs, and his improvement of delusional symptoms was coincident with normalization of frontal executive function.
In conclusion, these findings suggest that right midbrain infarctions should be regarded as a potential cause for the sudden occurrence of delusions without hallucinations in elderly individuals.

Footnote

The authors have confirmed that details of the case have been disguised to protect patient privacy.

References

1.
Kronenburg A, Spliet WG, Broekman M, et al: Locus coeruleus syndrome as a complication of tectal surgery. BMJ Case Rep (Epub ahead of print, April 22, 2015) pii: bcr2014207018.
2.
Nishio Y, Ishii K, Kazui H, et al: Frontal-lobe syndrome and psychosis after damage to the brainstem dopaminergic nuclei. J Neurol Sci 2007; 260:271–274
3.
Roberts JK, Trimble MR, Robertson M: Schizophrenic psychosis associated with aqueduct stenosis in adults. J Neurol Neurosurg Psychiatry 1983; 46:892–898
4.
Folstein MF, Folstein SE, McHugh PR: “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189–198
5.
Wechsler D: Manual for the Wechsler Memory Scale–Revised. New York, Psychological Corporation, 1987
6.
Azouvi P, Olivier S, de Montety G, et al: Behavioral assessment of unilateral neglect: study of the psychometric properties of the Catherine Bergego Scale. Arch Phys Med Rehabil 2003; 84:51–57.
7.
Ishiai S: Behavioural Inattention Test, Japanese ed. Tokyo, Shinkoh Igaku Shuppan Corporation, 1999
8.
Dubois B, Slachevsky A, Litvan I, et al: The FAB: a Frontal Assessment Battery at bedside. Neurology 2000; 55:1621–1626
9.
Ishiai S, Umeda S, Funayama M: Trail Making Test, Japanese ed. Tokyo, Shinkoh Igaku Shuppan Corporation, 2019
10.
Kashima H: Behavioural Assessment of the Dysexecutive Syndrome, Japanese ed. Tokyo, Shinkoh Igaku Shuppan Corporation, 2003
11.
Appollonio I, Leone M, Isella V, et al: The Frontal Assessment Battery (FAB): normative values in an Italian population sample. Neurol Sci 2005; 26:108–116
12.
Kölmel HW: Peduncular hallucinations. J Neurol 1991; 238:457–459
13.
Darby R, Prasad S: Lesion-related delusional misidentification syndromes: a comprehensive review of reported cases. J Neuropsychiatry Clin Neurosci 2016; 28:217–222
14.
Stangeland H, Orgeta V, Bell V: Poststroke psychosis: a systematic review. J Neurol Neurosurg Psychiatry 2018; 89:879–885
15.
Devinsky O: Delusional misidentifications and duplications: right brain lesions, left brain delusions. Neurology 2009; 72:80–87
16.
Coltheart M: The neuropsychology of delusions. Ann N Y Acad Sci 2010; 1191:16–26
17.
Cacciola A, Milardi D, Anastasi GP, et al: A direct cortico-nigral pathway as revealed by constrained spherical deconvolution tractography in humans. Front Hum Neurosci 2016; 10:374

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: 302 - 304
PubMed: 31564235

History

Received: 21 April 2019
Revision received: 27 June 2019
Accepted: 29 July 2019
Published online: 30 September 2019
Published in print: Summer 2020

Keywords

  1. Delusions
  2. Infarction
  3. Midbrain
  4. Substantia Nigra
  5. Frontal-Executive Function Depersonalization
  6. Geriatric Neuropsychiatry

Authors

Affiliations

Kazutaka Sakamoto, O.T.R., M.S. [email protected]
The Department of Rehabilitation, Shinoda General Hospital, Yamagata City, Yamagata, Japan (Sakamoto, Okada, Sato); the Department of Occupational Therapy, Graduate School of Health Sciences, Yamagata Prefectural University of Health Sciences, Yamagata City, Yamagata, Japan (Sakamoto, Yokoi, Hirayama); the Medical Center for Dementia, Shinoda General Hospital, Yamagata City, Yamagata, Japan (Kawakatsu, Kobayashi); the Department of Neuropsychiatry, Aizu Medical Center, Fukushima Medical University, Tanisawa, Kawahigashi, Aizuwakamatsu City, Fukushima, Japan (Kawakatsu); the Department of Psychiatry, Yamagata University School of Medicine, Yamagata City, Yamagata, Japan (Kobayashi, Otani); and the Department of Neurosurgery, Shinoda General Hospital, Yamagata City, Yamagata, Japan (Kunihiro).
Kayoko Yokoi, O.T.R., Ph.D.
The Department of Rehabilitation, Shinoda General Hospital, Yamagata City, Yamagata, Japan (Sakamoto, Okada, Sato); the Department of Occupational Therapy, Graduate School of Health Sciences, Yamagata Prefectural University of Health Sciences, Yamagata City, Yamagata, Japan (Sakamoto, Yokoi, Hirayama); the Medical Center for Dementia, Shinoda General Hospital, Yamagata City, Yamagata, Japan (Kawakatsu, Kobayashi); the Department of Neuropsychiatry, Aizu Medical Center, Fukushima Medical University, Tanisawa, Kawahigashi, Aizuwakamatsu City, Fukushima, Japan (Kawakatsu); the Department of Psychiatry, Yamagata University School of Medicine, Yamagata City, Yamagata, Japan (Kobayashi, Otani); and the Department of Neurosurgery, Shinoda General Hospital, Yamagata City, Yamagata, Japan (Kunihiro).
Shinobu Kawakatsu, M.D., Ph.D.
The Department of Rehabilitation, Shinoda General Hospital, Yamagata City, Yamagata, Japan (Sakamoto, Okada, Sato); the Department of Occupational Therapy, Graduate School of Health Sciences, Yamagata Prefectural University of Health Sciences, Yamagata City, Yamagata, Japan (Sakamoto, Yokoi, Hirayama); the Medical Center for Dementia, Shinoda General Hospital, Yamagata City, Yamagata, Japan (Kawakatsu, Kobayashi); the Department of Neuropsychiatry, Aizu Medical Center, Fukushima Medical University, Tanisawa, Kawahigashi, Aizuwakamatsu City, Fukushima, Japan (Kawakatsu); the Department of Psychiatry, Yamagata University School of Medicine, Yamagata City, Yamagata, Japan (Kobayashi, Otani); and the Department of Neurosurgery, Shinoda General Hospital, Yamagata City, Yamagata, Japan (Kunihiro).
Ryota Kobayashi, M.D.
The Department of Rehabilitation, Shinoda General Hospital, Yamagata City, Yamagata, Japan (Sakamoto, Okada, Sato); the Department of Occupational Therapy, Graduate School of Health Sciences, Yamagata Prefectural University of Health Sciences, Yamagata City, Yamagata, Japan (Sakamoto, Yokoi, Hirayama); the Medical Center for Dementia, Shinoda General Hospital, Yamagata City, Yamagata, Japan (Kawakatsu, Kobayashi); the Department of Neuropsychiatry, Aizu Medical Center, Fukushima Medical University, Tanisawa, Kawahigashi, Aizuwakamatsu City, Fukushima, Japan (Kawakatsu); the Department of Psychiatry, Yamagata University School of Medicine, Yamagata City, Yamagata, Japan (Kobayashi, Otani); and the Department of Neurosurgery, Shinoda General Hospital, Yamagata City, Yamagata, Japan (Kunihiro).
Kana Kunihiro, M.D.
The Department of Rehabilitation, Shinoda General Hospital, Yamagata City, Yamagata, Japan (Sakamoto, Okada, Sato); the Department of Occupational Therapy, Graduate School of Health Sciences, Yamagata Prefectural University of Health Sciences, Yamagata City, Yamagata, Japan (Sakamoto, Yokoi, Hirayama); the Medical Center for Dementia, Shinoda General Hospital, Yamagata City, Yamagata, Japan (Kawakatsu, Kobayashi); the Department of Neuropsychiatry, Aizu Medical Center, Fukushima Medical University, Tanisawa, Kawahigashi, Aizuwakamatsu City, Fukushima, Japan (Kawakatsu); the Department of Psychiatry, Yamagata University School of Medicine, Yamagata City, Yamagata, Japan (Kobayashi, Otani); and the Department of Neurosurgery, Shinoda General Hospital, Yamagata City, Yamagata, Japan (Kunihiro).
Oyuki Okada, S.T.
The Department of Rehabilitation, Shinoda General Hospital, Yamagata City, Yamagata, Japan (Sakamoto, Okada, Sato); the Department of Occupational Therapy, Graduate School of Health Sciences, Yamagata Prefectural University of Health Sciences, Yamagata City, Yamagata, Japan (Sakamoto, Yokoi, Hirayama); the Medical Center for Dementia, Shinoda General Hospital, Yamagata City, Yamagata, Japan (Kawakatsu, Kobayashi); the Department of Neuropsychiatry, Aizu Medical Center, Fukushima Medical University, Tanisawa, Kawahigashi, Aizuwakamatsu City, Fukushima, Japan (Kawakatsu); the Department of Psychiatry, Yamagata University School of Medicine, Yamagata City, Yamagata, Japan (Kobayashi, Otani); and the Department of Neurosurgery, Shinoda General Hospital, Yamagata City, Yamagata, Japan (Kunihiro).
Yuichiro Sato, O.T.R.
The Department of Rehabilitation, Shinoda General Hospital, Yamagata City, Yamagata, Japan (Sakamoto, Okada, Sato); the Department of Occupational Therapy, Graduate School of Health Sciences, Yamagata Prefectural University of Health Sciences, Yamagata City, Yamagata, Japan (Sakamoto, Yokoi, Hirayama); the Medical Center for Dementia, Shinoda General Hospital, Yamagata City, Yamagata, Japan (Kawakatsu, Kobayashi); the Department of Neuropsychiatry, Aizu Medical Center, Fukushima Medical University, Tanisawa, Kawahigashi, Aizuwakamatsu City, Fukushima, Japan (Kawakatsu); the Department of Psychiatry, Yamagata University School of Medicine, Yamagata City, Yamagata, Japan (Kobayashi, Otani); and the Department of Neurosurgery, Shinoda General Hospital, Yamagata City, Yamagata, Japan (Kunihiro).
Koichi Otani, M.D., Ph.D.
The Department of Rehabilitation, Shinoda General Hospital, Yamagata City, Yamagata, Japan (Sakamoto, Okada, Sato); the Department of Occupational Therapy, Graduate School of Health Sciences, Yamagata Prefectural University of Health Sciences, Yamagata City, Yamagata, Japan (Sakamoto, Yokoi, Hirayama); the Medical Center for Dementia, Shinoda General Hospital, Yamagata City, Yamagata, Japan (Kawakatsu, Kobayashi); the Department of Neuropsychiatry, Aizu Medical Center, Fukushima Medical University, Tanisawa, Kawahigashi, Aizuwakamatsu City, Fukushima, Japan (Kawakatsu); the Department of Psychiatry, Yamagata University School of Medicine, Yamagata City, Yamagata, Japan (Kobayashi, Otani); and the Department of Neurosurgery, Shinoda General Hospital, Yamagata City, Yamagata, Japan (Kunihiro).
Kazumi Hirayama, M.D., Ph.D.
The Department of Rehabilitation, Shinoda General Hospital, Yamagata City, Yamagata, Japan (Sakamoto, Okada, Sato); the Department of Occupational Therapy, Graduate School of Health Sciences, Yamagata Prefectural University of Health Sciences, Yamagata City, Yamagata, Japan (Sakamoto, Yokoi, Hirayama); the Medical Center for Dementia, Shinoda General Hospital, Yamagata City, Yamagata, Japan (Kawakatsu, Kobayashi); the Department of Neuropsychiatry, Aizu Medical Center, Fukushima Medical University, Tanisawa, Kawahigashi, Aizuwakamatsu City, Fukushima, Japan (Kawakatsu); the Department of Psychiatry, Yamagata University School of Medicine, Yamagata City, Yamagata, Japan (Kobayashi, Otani); and the Department of Neurosurgery, Shinoda General Hospital, Yamagata City, Yamagata, Japan (Kunihiro).

Notes

Send correspondence to Dr. Sakamoto ([email protected]).

Competing Interests

The authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share